These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
778 related items for PubMed ID: 10772807
1. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells. Bilodeau JF, Faure R, Piedboeuf B, Mirault ME. Exp Cell Res; 2000 May 01; 256(2):347-57. PubMed ID: 10772807 [Abstract] [Full Text] [Related]
2. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S. Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451 [Abstract] [Full Text] [Related]
3. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM. Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461 [Abstract] [Full Text] [Related]
4. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J, Ammanamanchi S, Ko TC, Brattain MG. Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668 [Abstract] [Full Text] [Related]
5. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA. Oncogene; 1998 Feb 12; 16(6):721-36. PubMed ID: 9488036 [Abstract] [Full Text] [Related]
6. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells. Park US, Park SK, Lee YI, Park JG, Lee YI. Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595 [Abstract] [Full Text] [Related]
7. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G, Hunter T, Ruoslahti E. Oncogene; 1998 May 13; 16(20):2575-83. PubMed ID: 9632134 [Abstract] [Full Text] [Related]
8. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
9. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace AJ, O'Connor PM. Oncogene; 1996 Feb 01; 12(3):595-607. PubMed ID: 8637717 [Abstract] [Full Text] [Related]
10. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]
11. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y. Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993 [Abstract] [Full Text] [Related]
12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 07; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
13. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA. Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579 [Abstract] [Full Text] [Related]
14. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction. Ponzio G, Loubat A, Rochet N, Turchi L, Rezzonico R, Farahi Far D, Dulic V, Rossi B. Oncogene; 1998 Sep 03; 17(9):1159-66. PubMed ID: 9764826 [Abstract] [Full Text] [Related]
15. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S, Lowe M, Herliczek TW, Keyomarsi K. Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471 [Abstract] [Full Text] [Related]
16. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J. Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932 [Abstract] [Full Text] [Related]
17. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M. Hepatology; 2001 May 09; 33(5):1087-97. PubMed ID: 11343236 [Abstract] [Full Text] [Related]
18. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related]
19. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Medema RH, Klompmaker R, Smits VA, Rijksen G. Oncogene; 1998 Jan 29; 16(4):431-41. PubMed ID: 9484832 [Abstract] [Full Text] [Related]
20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV. Oncogene; 1999 Oct 07; 18(41):5611-9. PubMed ID: 10523840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]